PCT & Support

Farestos 20 mg Pharmacom Labs

Pharmacom Labs

50,00

In Stock (100 available)

Farestos 20 mg Pharmacom Labs (20 mg) — Precision-dosed by Pharmacom Labs for consistent results, this Selective Estrogen Receptor Modulator (SERM) provides targeted estr…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

Farestos 20 mg Pharmacom Labs — Precision-dosed for consistent results, this Selective Estrogen Receptor Modulator (SERM) provides targeted estrogen blocking for PCT and gynecomastia prevention. Similar mechanism to Tamoxifen with potentially fewer side effects. This formulation is dosed at 20 mg per unit.

Key Benefits

  • SERM — selectively blocks estrogen at the breast tissue (no gyno)
  • Does not lower systemic E2 (unlike AIs) — safer for lipids
  • PCT workhorse — stimulates LH/FSH release via hypothalamic feedback
  • Available as generic — reliably priced worldwide
  • Standard dose 20 mg/day; PCT protocols 20–40 mg/day
  • Each unit dosed at 20 mg — see Recommended Dosage below for protocol-specific intake

Quality Assurance

Pharmacom Labs is committed to delivering pharmaceutical-grade compounds with verified potency, purity, and sterility. Every batch undergoes rigorous third-party laboratory testing to ensure accurate dosing and absence of contaminants. With Pharmacom Labs, you receive a product backed by strict GMP manufacturing standards and complete traceability from raw material to finished product.

How It Works

Selective estrogen receptor modulator (SERM). Antagonises the estrogen receptor in breast tissue (prevents gyno) while acting as a partial agonist at the hypothalamus (stimulates LH/FSH release) and liver (maintains favourable lipids).

Pharmacokinetics

Plasma half-life approximately 5–7 days (active metabolite 14 days). Once-daily dosing. Long action tail — consider when planning PCT timeline.

Cycle & Stacking Guide

On-cycle: 10–20 mg/day if prone to gyno. PCT: 20–40 mg/day for 4 weeks, starting 14 days after last long-ester injection (or 3–5 days after short-ester). Often paired with Clomid for stronger LH stimulation.

Manufacturer Notes

Pharmacom Labs operates from EU-registered facilities with in-house HPLC verification. Every batch ships with a unique code on the label — scannable at pharmacom-labs.com to confirm authenticity before the vial ever leaves the box.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Farestos 20 mg Pharmacom Labs”

Your email address will not be published. Required fields are marked *